The $100 Billion Genomic Revolution: Your Grandchildren Could Take CRISPR Like a Vitamin!

A Quiet Revolution

Technologies that shape the future often evolve by converging rather than in isolation. Genomics is one of the strongest examples. In late 2023, the US Food and Drug Administration (FDA) approved the first CRISPR-based gene-editing treatment developed for sickle cell anemia. However, this reflects more than CRISPR alone: gene therapies, genetic sequencing technologies and bioinformatics platforms are maturing simultaneously.

Between 2023 and 2030, this field is expected to reach a market value exceeding $100 billion . Yet this figure reflects only a small part of its true potential. These technologies are beginning to be used not only for rare diseases, but also for common diseases and even anti-aging applications.

Genetically Based Rare Diseases: Not So Rare After All

More than approximately 400 million people worldwide have one of over 10 thousand rare diseases. Although these conditions are individually rare, together they affect about 6% of the world's population and impose a substantial burden. More than 80% of these diseases are known to have a genetic basis.

• According to the European Union: a rare disease affects fewer than 1 in 2000 people.

• US FDA definition: it must occur in fewer than 1 in 200000 people.

• Ultra-rare: fewer than 1 in 50000.

• Hyper-rare: fewer than 1 in 100 million people.

Although these figures show how much definitions of rare diseases vary, collectively at least one in every 20 people falls into this group.

CRISPR: From a Billions-of-Years-Old Defense System to a Medical Revolution

CRISPR in the 1980s was discovered as an immune system developed by bacteria against viruses. Palindromic repeats in bacterial DNA provided a defense mechanism by producing RNAs complementary to viral genetic material.

However, the real revolution began in 2012with a study published in Science. The paper, titled “Programmable Dual RNA-Guided DNA Endonuclease,” showed that the CRISPR-Cas9 system could precisely cut and edit DNA in the laboratory. Although it initially attracted limited attention, it soon opened the path to a Nobel Prize.

‼️CRISPR gene-editing technology earned Jennifer Doudna and Emmanuelle Charpentier the Nobel Prize in Chemistry in 2020 .

With the CRISPR-Cas9 system:

• A specific genetic region can be targeted.

• The Cas9 enzyme cuts this region, allowing gene editing.

• Corrections can be made at the cellular level.

Today, this technology has entered clinical trials for cancer, heart disease, hemophilia and even some forms of inherited blindness.

Moving From Rare Diseases to Common Diseases

In cardiologist and digital medicine pioneer Dr. Eric Topol's book “Super Agers,” chapter 8 explains why rare diseases are actually central to the science of aging. This perspective makes a clear point:

“The genetic technologies we develop today to treat what is 'rare' will lay the foundations for treating tomorrow's common diseases.”

As Eric Topol also notes, genome editing could become as routine in our grandchildren's lives as taking vitamins is today.

The Future of Health: Shaped by Genetics

Thanks to this genomic revolution:

• Genetic screening will become less expensive and more widespread.

• Treatments will become personalized.

• Diseases could be prevented genetically before they even begin.

Moreover, just as mRNA technology succeeded during the pandemic, platform technologies such as CRISPR will provide a foundation for new applications. Like the work of Katalin Karikó and Drew Weissman on mRNA, CRISPR is a technological breakthrough whose value became clear years later.

Conclusion: Genetic Technologies Are Only the Beginning

CRISPR and similar gene-editing technologies are opening the door to a new era in health care. In the coming years, we will see far greater effects on both lifespan and quality of life. Beyond a $100 billion market, our vision of human health is also changing.

And perhaps one day, our grandchildren will consider CRISPR so routine that they take a daily dose just like a multivitamin.